Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:1180-1188
Published online before print February 27, 2006, doi: 10.1161/CIRCULATIONAHA.105.582890
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
113/9/1180    most recent
CIRCULATIONAHA.105.582890v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sutherland, A. J.
Right arrow Articles by West, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sutherland, A. J.
Right arrow Articles by West, M. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Coronary Artery Disease
Related Collections
Right arrow Remodeling
Right arrow CV surgery: coronary artery disease
Right arrow Mechanism of atherosclerosis/growth factors

(Circulation. 2006;113:1180-1188.)
© 2006 American Heart Association, Inc.


Cardiovascular Surgery

Vascular Remodeling in the Internal Mammary Artery Graft and Association With In Situ Endothelin-1 and Receptor Expression

Allison J. Sutherland, BSc (Hons), PhD; Maria I. Nataatmadja, MDSc, PhD; Philip J. Walker, MBBS, FRACS; Leila Cuttle, BSc (Hons); R. Bruce Garlick, MBBS (Hons), FRACS; Malcolm J. West, MBBS, PhD, FRACP

From the Department of Surgery, The University of Queensland, Royal Brisbane and Women’s Hospital (A.J.S., P.J.W.); Department of Medicine, The University of Queensland, The Prince Charles Hospital (M.I.N., M.J.W.); Department of Paediatrics and Child Health, The University of Queensland, Royal Children’s Hospital Research Centre (L.C.); and Department of Cardiac Surgery, The Prince Charles Hospital and Holy Spirit Northside Hospital (R.B.G.), Brisbane, Australia.

Correspondence to Allison Sutherland, BSc (Hons), PhD, Department of Surgery, The University of Queensland, Clinical Sciences Bldg, Royal Brisbane and Women’s Hospital, Herston Rd, Herston, Queensland 4029, Australia.

Received August 15, 2005; revision received November 24, 2005; accepted December 14, 2005.

Background— The vasoconstricting peptide endothelin-1 (ET-1) has been associated with atherosclerotic cardiovascular disease, vascular smooth muscle cell (VSMC) growth stimulation, and intimal thickening. ET-1 binds 2 receptor subtypes, endothelin A and B, and the ETA receptor mediates vasoconstriction and VSMC growth. This study aims to quantitatively assess arterial remodeling variables and compare them with changes in ET-1, ETA, and ETB expression in the internal mammary artery (IMA).

Methods and Results— Specimens from 55 coronary artery disease (CAD) patients (45 men, 10 women; mean age 65 years) and 14 control IMA specimens (from 7 men and 7 women; mean age 45 years) were collected. IMA cross sections were assessed by histochemical and immunohistochemical staining methods to quantify the levels of medionecrosis, fibrosis, VSMC growth, ET-1, ETA, ETB, and macrophage infiltration. The percentage area of medionecrosis in the patients was almost double that in the controls (31.85±14.52% versus 17.10±9.96%, P=0.0006). Total and type 1 collagen was significantly increased compared with controls (65.8±18.3% versus 33.7±13.7%, P=0.07, and 14.2±10.0% versus 4.8±2.8%, P=0.01, respectively). Despite ACE and/or statin therapy, ET-1 expression and cell cycling were significantly elevated in the patient IMAs relative to the controls (46.27±18.46 versus 8.56±8.42, P=0.0001, and 37.29±12.88 versus 11.06±8.18, P=0.0001, respectively). ETA and ETB staining was elevated in the patient vessels (46.88±11.52% versus 18.58±7.65%, P=0.0001, and 42.98±7.08% versus 34.73±5.20%, P=0.0067, respectively). A mild presence of macrophages was noted in all sections.

Conclusions— Elevated distribution of collagen indicative of fibrosis coupled with increased cell cycling and high levels of ET-1 and ETA expression in the absence of chronic inflammation suggests altered IMA VSMC regulation is fundamental to the remodeling process.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Foglieni, F. Maisano, L. Dreas, A. Giazzon, G. Ruotolo, E. Ferrero, L. Li Volsi, S. Coli, G. Sinagra, B. Zingone, et al.
Mild inflammatory activation of mammary arteries in patients with acute coronary syndromes
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2831 - H2837.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Bohm and J. Pernow
The importance of endothelin-1 for vascular dysfunction in cardiovascular disease
Cardiovasc Res, October 1, 2007; 76(1): 8 - 18.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. G.M. Molin and M. J. Post
Do intrinsic arterial wall features determine atherosclerosis susceptibility?
Cardiovasc Res, October 1, 2006; 72(1): 3 - 4.
[Full Text] [PDF]


Home page
CirculationHome page
M. Gossl and A. Lerman
Endothelin: Beyond a Vasoconstrictor
Circulation, March 7, 2006; 113(9): 1156 - 1158.
[Full Text] [PDF]